{
    "nct_id": "NCT04282967",
    "official_title": "IIT2019-14-SHIRAZIP-SWEAT: Streaming Web-based Exercise At Home: A Pilot Study",
    "inclusion_criteria": "* Male previously diagnosed with prostate cancer or female previously diagnosed with breast cancer.\n* For breast cancer, minimum of 3 months post-active treatment completion. Active treatment includes chemotherapy, biologic therapy, radiation therapy, surgery, and any combination. Long-term hormonal/biologic treatments are acceptable.\n* For prostate cancer, minimum of 3 months post-active treatment completion. Active treatment includes chemotherapy, biologic therapy, radiation therapy, surgery, and any combination. Long-term hormonal/biologic treatments are acceptable, except for androgen receptor-targeted therapies (such as enzalutamide, apalutamide, darolutamide, or abiraterone). Patients currently on active surveillance are eligible even if they have not received prior anti-cancer treatment.\n* Has access to tablet, laptop, or desktop computer with video capabilities connected to the internet with a screen at least 13 inches across.\n* Physically able to complete modified Bruce submaximal treadmill test, leg strength test, grip strength test, and InBody per patient self-assessment.\n* Physician clearance to participate in this study. Can be done through review of patients' medical records.\n* Ability to read, write, and understand English.\n* Has a chair at home to use for exercise that is not on wheels and has a solid back (not a reclining chair).\n* Ambulatory without assistance.\n* Has a clear 5 x 6-foot space at home in which to exercise.\n* Age >18 years.\n* Written informed consent obtained from subject and ability for subject to comply with the requirements of the study.\nHealthy volunteers allowed\nMust have minimum age of 18 Years",
    "exclusion_criteria": "* Active treatment planned within the next 6 months. Active treatment includes chemotherapy, biologic therapy, radiation therapy, surgery, and any combination. Long-term hormonal/biologic treatments are acceptable, except for AR-targeted therapies for prostate cancer.\n* Known metastatic disease.\n* Grade 3 or higher peripheral neuropathy.\n* Major surgery within 3 months of baseline visit.\n* Positive pregnancy test for women of child-bearing potential.\n* Answers yes to any question on the Physical Activity Readiness Questionnaire unless study participation is cleared by a physician.\n* Known allergy to Fitbit device.\n* Currently meeting physical activity guidelines (score of >23 on Godin-Shephard Leisure-Time Physical Activity Questionnaire).",
    "miscellaneous_criteria": ""
}